{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:28:58Z","timestamp":1777181338747,"version":"3.51.4"},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1111\/jcpt.12216","type":"journal-article","created":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T05:02:33Z","timestamp":1412744553000},"page":"1-6","source":"Crossref","is-referenced-by-count":29,"title":["A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia"],"prefix":"10.1155","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2203-6106","authenticated-orcid":false,"given":"L. A.","family":"VanderWeide","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy; University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; Aurora CO USA"},{"name":"Department of Pharmacy; The Ohio State University Wexner Medical Center; Columbus OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Smith","sequence":"additional","affiliation":[{"name":"Departments of Pharmacotherapy & Translational Research and Community Health & Family Medicine; Colleges of Pharmacy and Medicine; University of Florida; Gainesville FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. E.","family":"Trinkley","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy; University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; Aurora CO USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,8]]},"reference":[{"key":"10.1111\/jcpt.12216-BIB0001|jcpt12216-cit-0001","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 critera for the classification of fibromyalgia - report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jcpt.12216-BIB0002|jcpt12216-cit-0002","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1111\/jcpt.12216-BIB0003|jcpt12216-cit-0003","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/keg075","article-title":"Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals","volume":"42","author":"Fitzcharles","year":"2003","journal-title":"Rheumatology"},{"key":"10.1111\/jcpt.12216-BIB0004|jcpt12216-cit-0004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/fampra\/14.3.238","article-title":"Awareness of diagnostic and clinical features of fibromyalgia among family physicians","volume":"14","author":"Buskila","year":"1997","journal-title":"Fam Pract"},{"key":"10.1111\/jcpt.12216-BIB0005|jcpt12216-cit-0005","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed, and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1111\/jcpt.12216-BIB0006|jcpt12216-cit-0006","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2310\/JIM.0b013e31824963d1","article-title":"Prevalence of fibromyalgia syndrome in patients referred to a tertiary pain clinic","volume":"60","author":"Brill","year":"2012","journal-title":"J Investig Med"},{"key":"10.1111\/jcpt.12216-BIB0007|jcpt12216-cit-0007","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/01.rhu.0000221817.46231.18","article-title":"The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes","volume":"12","author":"Weir","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/jcpt.12216-BIB0008|jcpt12216-cit-0008","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jcpt.12216-BIB0009|jcpt12216-cit-0009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/CEOR.S41111","article-title":"Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States","volume":"5","author":"Knight","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1111\/jcpt.12216-BIB0010|jcpt12216-cit-0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Manage"},{"key":"10.1111\/jcpt.12216-BIB0011|jcpt12216-cit-0011","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.292.19.2388","article-title":"Management of fibromyalgia syndrome","volume":"292","author":"Goldenberg","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1111\/jcpt.12216-BIB0012|jcpt12216-cit-0012","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122","author":"Bradley","year":"2009","journal-title":"Am J Med"},{"issue":"3","key":"10.1111\/jcpt.12216-BIB0013|jcpt12216-cit-0013","first-page":"CD008244","article-title":"Milnacipran for neuropathic pain and fibromyalgia in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12216-BIB0014|jcpt12216-cit-0014","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1111\/jcpt.12216-BIB0015|jcpt12216-cit-0015","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10067-009-1203-2","article-title":"Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials","volume":"28","author":"Choy","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1111\/jcpt.12216-BIB0016|jcpt12216-cit-0016","first-page":"CD007115","article-title":"Duloxetine for treating painful neuropathy or chronic pain","author":"Lunn","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12216-BIB0017|jcpt12216-cit-0017","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1533-2500.2011.00453.x","article-title":"Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care","volume":"11","author":"Kleinman","year":"2011","journal-title":"Pain Pract"},{"key":"10.1111\/jcpt.12216-BIB0018|jcpt12216-cit-0018","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2710.2010.01177.x","article-title":"Treatment of irritable bowel syndrome","volume":"36","author":"Trinkley","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12216-BIB0019|jcpt12216-cit-0019","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0033-3182(98)71375-1","article-title":"An open clinical trial of venlafaxine treatment of fibromyalgia","volume":"39","author":"Dwight","year":"1998","journal-title":"Psychosomatics"},{"key":"10.1111\/jcpt.12216-BIB0020|jcpt12216-cit-0020","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1345\/aph.1D112","article-title":"Venlafaxine treatment of fibromyalgia","volume":"37","author":"Sayar","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12216-BIB0021|jcpt12216-cit-0021","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1016\/S0924-977X(04)80512-1","article-title":"Treatment of pain, depressive and anxiety symptoms in fibromyalgia with venlafaxine","volume":"14","author":"Evren","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1111\/jcpt.12216-BIB0022|jcpt12216-cit-0022","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.psym.2010.12.014","article-title":"Psychological factors affecting response to antidepressant drugs in fibromyalgia","volume":"52","author":"Diaz-Marsa","year":"2011","journal-title":"Psychosomatics"},{"key":"10.1111\/jcpt.12216-BIB0023|jcpt12216-cit-0023","first-page":"S105","article-title":"Venlafaxine in fibromyalgia: results of a randomized, placebo-controlled, double-blind trial","volume":"46","author":"Zijlstra","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jcpt.12216-BIB0024|jcpt12216-cit-0024","unstructured":"American College of Rheumatology (US) Fibromyalgia Impact Questionnaire (FIQ) [Internet] 2013 http:\/\/www.rheumatology.org\/Practice\/Clinical\/Clinicianresearchers\/Outcomes_Instrumentation\/Fibromyalgia_Impact_Questionnaire_(FIQ"},{"key":"10.1111\/jcpt.12216-BIB0025|jcpt12216-cit-0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jama.2014.7523","article-title":"The intention-to-treat principle: how to assess the true effect of choosing a medical treatment","volume":"312","author":"Detry","year":"2014","journal-title":"J Am Med Assoc"},{"key":"10.1111\/jcpt.12216-BIB0026|jcpt12216-cit-0026","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpsychires.2007.01.008","article-title":"A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder","volume":"42","author":"Perahia","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1111\/jcpt.12216-BIB0027|jcpt12216-cit-0027","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/YIC.0b013e3282f424c2","article-title":"Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor","volume":"23","author":"Lenox-Smith","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1111\/jcpt.12216-BIB0028|jcpt12216-cit-0028","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.biopsych.2007.04.040","article-title":"The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: outcomes from the acute and continuation phases","volume":"62","author":"Keller","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1111\/jcpt.12216-BIB0029|jcpt12216-cit-0029","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/2045125312472890","article-title":"A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdose","volume":"3","author":"Taylor","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1111\/jcpt.12216-BIB0030|jcpt12216-cit-0030","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.081090","article-title":"Minimal clinically important difference in the fibromyalgia impact questionnaire","volume":"36","author":"Bennett","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1111\/jcpt.12216-BIB0031|jcpt12216-cit-0031","first-page":"231926","article-title":"Definition of nonresponse to analgesic treatment of arthritic pain: an analytical literature review of the smallest detectable difference, the minimal detectable change, and the minimal clinically important difference on the pain visual analog scale","volume":"2011","author":"Stauffer","year":"2011","journal-title":"Int J Inflam"},{"key":"10.1111\/jcpt.12216-BIB0032|jcpt12216-cit-0032","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"Suppl 22","key":"10.1111\/jcpt.12216-BIB0033|jcpt12216-cit-0033","first-page":"29","article-title":"Clinical guidelines for establishing remission in patients with depression and anxiety","volume":"60","author":"Ballenger","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/jcpt.12216-BIB0034|jcpt12216-cit-0034","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.psychres.2004.03.014","article-title":"Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression","volume":"135","author":"Hiroe","year":"2005","journal-title":"Psychiatry Res"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12216","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12216","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12216\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:35Z","timestamp":1671818735000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12216","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,8]]}}}